Company Filing History:
Years Active: 1992-1993
Title: **The Innovative Mind of Brian E McLaughlin: A Pioneer in Hemostasis Valve Technology**
Introduction
Brian E McLaughlin, a talented inventor based in Salem, MA, has made significant strides in medical technology with his innovative work in the development of hemostasis valves. With two patents to his name, McLaughlin continues to contribute to advancements in medical devices, ensuring better patient outcomes and safer procedures.
Latest Patents
Among his latest innovations, McLaughlin's design of a self-sealing, penetrable hemostasis valve stands out. This valve is specifically engineered for catheter introducers and features an elastomeric gasket member with first and second opposed faces, which are crafted to secure in a valve housing. The unique design includes generally concave surfaces aimed at reducing the central thickness of the gasket member. Each face contains pinholes or slits that facilitate the introduction of interventional devices while maintaining hemostasis during procedures. The sophisticated molding of the gasket member into convex cusp-shaped surfaces enhances the valve's functionality, allowing for improved access without compromising the seal.
Career Highlights
Currently, McLaughlin is associated with Medtronic, Inc., where he continues to explore new frontiers in medical technology. His contributions to the field are not only limited to his patents but also extend to enhancing the overall workings of medical device systems, providing essential innovations for healthcare professionals.
Collaborations
Throughout his career, McLaughlin has collaborated closely with colleagues such as Thomas R Johnson, whose expertise complements McLaughlin’s inventive approach. Together, they explore the complexities of medical device design and functionality, showcasing the power of teamwork in innovation.
Conclusion
Brian E McLaughlin represents a remarkable figure in the realm of medical inventions. His dedication to developing advanced hemostasis valves reflects a commitment to improving patient care and procedural effectiveness. As medical technology continues to evolve, innovators like McLaughlin will undoubtedly play a crucial role in shaping the future of healthcare.